ALFACELL CORP
SC 13G, 1998-07-20
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SILICON VALLEY RESEARCH INC, PRE 14A, 1998-07-20
Next: CHAD THERAPEUTICS INC, DEF 14A, 1998-07-20




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                    -----------------------------------------


                                  SCHEDULE 13G
                    Under the Securities Exchange Act of 1934
                    -----------------------------------------


                              ALFACELL CORPORATION
                    -----------------------------------------
                                (Name of Issuer)


                    Common Stock, par value $0.001 per share
                   ------------------------------------------
                         (Title of Class of Securities)

                                    015404106
                                  -------------
                                 (CUSIP Number)

                                  July 10, 1998
                                -----------------
             (Date of Event Which Requires Filing of the Statement)

         Check the  appropriate box to designate the rule pursuant to which this
Schedule is filed:

                                            [_]   Rule 13d-1(b)
                                            [X]   Rule 13d-1(c)
                                            [_]   Rule 13d-1(d)

         *The  remainder  of this cover page shall be filled out for a reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

         The information  required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however,  see
the Notes to Schedule 13G).

                                        1

<PAGE>

CUSIP NO. 015404106                    13G                    page 2 of 12 pages
- ----------                                                                 


     1     NAMES OF REPORTING PERSONS
           S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
           Paramount Capital Asset Management, Inc.

     2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
                                                              (a)[_] (b)[_]

     3     SEC USE ONLY

     4     SOURCE OF FUNDS*
           OO (see Item 3 below)

     5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
           ITEM 2(d) or 2(e)

                                                       [_]
     6     CITIZENSHIP OR PLACE OF ORGANIZATION
           Delaware

                 NUMBER OF                     7      SOLE VOTING POWER       
                  SHARES                              None                    
               BENEFICIALLY                    8      SHARED VOTING POWER     
                 OWNED BY                             2,019,800               
                   EACH                        9      SOLE DISPOSITIVE POWER  
                 REPORTING                            None                    
                  PERSON                      10      SHARED DISPOSITIVE POWER
                   WITH                               2,019,800               
                                                                              
                                              
       
                          
    11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           2,019,800

    12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
                                                                           [_] 
    13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
           11.1%

    14     TYPE OF REPORTING PERSON*
           CO

- ---------- -------------------------------

<PAGE>

CUSIP NO. 015404106                    13G                    page 3 of 12 pages
- ----------                                                                     


     1    NAMES OF REPORTING PERSONS S.S. OR I.R.S.  IDENTIFICATION NO. OF ABOVE
          PERSON

          Aries Domestic Fund, L.P.
    
     2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                               (a)[_]   (b)[_]
     3    SEC USE ONLY

     4    SOURCE OF FUNDS* OO (see Item 3 below)

     5    CHECK BOX IF DISCLOSURE OF LEGAL  PROCEEDINGS IS REQUIRED  PURSUANT TO
          ITEM 2(d) or 2(e)

                                                       [_]
     6    CITIZENSHIP OR PLACE OF ORGANIZATION
          Delaware

           NUMBER OF           7      SOLE VOTING POWER       
           SHARES                      None                   
        BENEFICIALLY           8      SHARED VOTING POWER        
          OWNED BY                     651,100                 
            EACH               9      SOLE DISPOSITIVE POWER   
          REPORTING                    None                    
           PERSON             10      SHARED DISPOSITIVE POWER 
            WITH                       651,100                 
                                                               
                                                               
                               
                                                              
    11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           651,100

    12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
                                                                        [_]
    13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
           3.7%

    14     TYPE OF REPORTING PERSON*
           PN



<PAGE>

CUSIP NO. 015404106                    13G                    page 4 of 12 pages
- ----------                                                                   


    1     NAMES OF REPORTING PERSONS
          S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          The Aries Trust

    2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                  (a)[_]
                                                                  (b)[_]
    3     SEC USE ONLY


    4     SOURCE OF FUNDS* OO (see Item 3 below)

    5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
          ITEM 2(d) or 2(e)
                                                                            [_]
    6     CITIZENSHIP OR PLACE OF ORGANIZATION
          Cayman Islands

                   NUMBER OF                    7     SOLE VOTING POWER
                    SHARES                             None
                 BENEFICIALLY                   8     SHARED VOTING POWER      
                   OWNED BY                            1,368,700                
                     EACH                       9     SOLE DISPOSITIVE POWER   
                   REPORTING                           None                     
                    PERSON                     10     SHARED DISPOSITIVE POWER 
                     WITH                              1,368,700        
                                                                 
                                

   11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
          1,368,700

   12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
                                                                       [_]
   13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
          7.7%

   14     TYPE OF REPORTING PERSON* OO (see Item 2)


<PAGE>


CUSIP NO. 015404106                    13G                    page 5 of 12 pages
- ----------                                                                     


     1    NAMES OF REPORTING PERSONS S.S. OR I.R.S.  IDENTIFICATION NO. OF ABOVE
          PERSON

          Lindsay A. Rosenwald, M.D.

     2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                    (a)[_]
                                                                    (b)[_]
     3    SEC USE ONLY


     4    SOURCE OF FUNDS* OO (see Item 3 below)

     5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
          ITEM 2(d) or 2(e)
                                                                   [_]
     6    CITIZENSHIP OR PLACE OF ORGANIZATION
          United States

                 NUMBER OF                     7      SOLE VOTING POWER
                  SHARES                               None
               BENEFICIALLY                    8      SHARED VOTING POWER      
                 OWNED BY                              2,019,800              
                   EACH                        9      SOLE DISPOSITIVE POWER  
                 REPORTING                             None                   
                  PERSON                      10      SHARED DISPOSITIVE POWER
                   WITH                                2,019,800              
                                                                              

    11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
          2,019,800

    12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
                                                                          [_]
    13    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
          11.1%

    14    TYPE OF REPORTING PERSON*
          IN


<PAGE>

Item 1.

          (a)  Name of Issuer:

               Alfacell Corporation

          (b)  Address of Issuer's Principal Executive Offices:

               Alfacell Corporation
               225 Bellville Ave.
               Bloomfield, NJ 07003
               973-748-8082

Item 2.

          (a)  Name of Person Filing:

               This  statement  is filed on behalf of  Paramount  Capital  Asset
               Management, Inc. ("Paramount Capital"), Aries Domestic Fund, L.P.
               ("Aries  Domestic"),  The Aries Fund,  a Class of the Aries Trust
               ("Aries Trust") and Lindsay A. Rosenwald,  M.D. ("Dr.  Rosenwald"
               and collectively,  "Reporting Parties").  See attached Exhibit A,
               which  is a copy of  their  agreement  in  writing  to file  this
               statement on behalf of each of them.

               Dr. Rosenwald is an investment banker,  venture capitalist,  fund
               manager and sole shareholder of Paramount Capital, a Subchapter S
               corporation  incorporated in Delaware.  Paramount  Capital is the
               General  Partner  of  Aries  Domestic,   a  limited   partnership
               incorporated in Delaware,  and is the Investment Manager to Aries
               Trust, a Cayman Islands Trust.

          (b)  Address of Principal Business Office or, if None, Residence:

               Paramount   Capital's,   Aries  Domestic's  and  Dr.  Rosenwald's
               business address is 787 Seventh Avenue, 48th Floor, New York, New
               York,  10019.  The  business  address  for  Aries  Trust  is  c/o
               MeesPierson  (Cayman)  Limited,  P.O. Box 2003,  British American
               Centre, Phase 3, Dr. Roy's Drive, George Town, Grand Cayman.

          (c)  Citizen:

               Dr. Rosenwald is a citizen of the United States.

          (d)  Title of Class of Securities:

               Common Stock, $0.001 par value ("shares").

          (e)  CUSIP#:

               015404106

Item 3.   Check the box if this statement is filed pursuant to Rule 13d-1(c) 
                                                                         [X]

                                        6

<PAGE>



Item 4.        Ownership:

               For  information  concerning  the ownership of Common
               Stock of the Company by the  Reporting  Persons,  see
               Items 5 through 11 of the cover  pages to this
               schedule 13G and footnotes thereto.

Item 5.        Ownership of Five Percent or Less of a Class:

               Not applicable.

Item 6.        Ownership of More than Five Percent on Behalf of Another Person:

               Not applicable.

Item 7.        Identification and Classification of the Subsidiary Which 
               Acquired the Security Being Reported On By the Parent Holding 
               Company:

               Not applicable.

Item 8.        Identification and Classification of Members of the Group:

               Not applicable.

Item 9.        Notice of Dissolution of Group:

               Not applicable.

Item 10.       Certification:

         By  signing  below I  certify  that,  to the best of my  knowledge  and
belief, the securities  referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing  the control of the
issuer of the  securities  and were not acquired and are not held in  connection
with or as a participant in any transaction having that purpose or effect.

                  Material to be Filed as Exhibits:

Exhibit A -       Copy of an  Agreement  between  Dr.  Rosenwald,  Paramount
                  Capital, Aries Domestic and Aries Trust to file this Statement
                  on Schedule 13G on behalf of each of them.

Exhibit B -       List of  executive  officers  and  directors  of Paramount
                  Capital  and  information  called  for by  Items  2-6 of  this
                  statement relating to said officers and directors.

Exhibit C -       List of executive officers and directors of Aries Domestic
                  and  information  called  for by Items  2-6 of this  statement
                  relating to said officers and directors.

Exhibit D -       List of executive  officers  and  directors of Aries Trust
                  and  information  called  for by Items  2-6 of this  statement
                  relating to said officers and directors.

                                        7

<PAGE>

                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and
belief,  I certify  that the  information  set forth in this  statement is true,
complete and correct.


                                 PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.

Dated:   July 20, 1998
          New York, NY              By /s/ Lindsay A. Rosenwald, M.D.
                                      -------------------------------
                                       Lindsay A. Rosenwald, M.D.
                                       President


                                 ARIES DOMESTIC FUND, L.P.
                                    By  Paramount Capital Asset Management, Inc.
                                         General Partner

Dated:   July 20, 1998
          New York, NY               By /s/ Lindsay A. Rosenwald, M.D.
                                       -------------------------------
                                        Lindsay A. Rosenwald, M.D.
                                        President


                                 THE ARIES TRUST
                                 By Paramount Capital Asset Management, Inc.
                                 Investment Manager

Dated:   July 20, 1998
          New York, NY             By /s/ Lindsay A. Rosenwald, M.D.
                                      -------------------------------
                                       Lindsay A. Rosenwald, M.D.
                                       President


Dated:   July 20, 1998
         New York, NY              By  /s/ Lindsay A. Rosenwald, M.D.
                                       ------------------------------
                                       Lindsay A. Rosenwald, M.D.

                                        8

<PAGE>

                                    EXHIBIT A

                                    AGREEMENT

                          JOINT FILING OF SCHEDULE 13G



         The  undersigned  hereby  agrees  to  jointly  prepare  and  file  with
regulatory  authorities  a  Schedule  13G  and  any  future  amendments  thereto
reporting  each  of  the  undersigned's  ownership  of  securities  of  Alfacell
Corporation,  and hereby  affirm that such Schedule 13G is being filed on behalf
of each of the undersigned.


                                 PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.

Dated:   July 20, 1998
          New York, NY             By /s/ Lindsay A. Rosenwald. M.D.
                                      ------------------------------
                                      Lindsay A. Rosenwald, M.D.
                                      President


                                 ARIES DOMESTIC FUND, L.P.
                                   By Paramount Capital Asset Management, Inc.
                                   General Partner

Dated:   July 20, 1998
          New York, NY             By /s/ Lindsay A. Rosenwald   M.D.
                                      ------------------------------
                                      Lindsay A. Rosenwald, M.D.
                                      President


                                 THE ARIES TRUST
                                   By Paramount Capital Asset Management, Inc.
                                   Investment Manager

Dated:   July 20, 1998
          New York, NY             By /s/ Lindsay A. Rosenwald   M.D. 
                                      ------------------------------  
                                      Lindsay A. Rosenwald, M.D.      
                                      President                       
Dated:   July 20, 1998          
          New York, NY             By  /s/ Lindsay Rosenwald, M.D.
                                       ---------------------------
                                       Lindsay A. Rosenwald, M.D.

                                        9

<PAGE>

                                    EXHIBIT B

         The name and principal occupation or employment, which in each instance
is with Paramount Capital Asset Management,  Inc. ("Paramount  Capital") located
at 787 Seventh Avenue,  48th Floor, New York, New York, 10019, of each executive
officer and director of Paramount Capital is as follows:

                                         PRINCIPAL OCCUPATION
         NAME                            OR EMPLOYMENT

Lindsay A. Rosenwald, M.D. Chairman of the Board, President of Paramount Capital
                           Asset Management, Inc., Paramount Capital
                           Investments LLC and Paramount Capital, Inc.

Peter Morgan Kash          Director of Paramount Capital Asset Management, Inc.,
                           Inc., Senior Managing Director, Paramount Capital,
                           Inc.

Dr. Yuichi Iwaki           Director of Paramount Capital Asset Management, Inc.,
                           Inc., Professor, University of Southern California
                           School of Medicine


Item 2.

         During  the five  years  prior to the date  hereof,  none of the  above
persons  (to the best of  Paramount  Capital's  knowledge)  was  convicted  in a
criminal  proceeding  (excluding traffic violations or similar  misdemeanors) or
was a party  to a civil  proceeding  of a  judicial  or  administrative  body of
competent jurisdiction,  as a result of which such person was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities subject to, Federal or State securities laws or finding
any violation with respect to such laws.

Items 3-6.

         Please refer to Items 3-6 herein reporting the beneficial ownership.

                                       10

<PAGE>

                                    EXHIBIT C

         The name and principal  occupation or employment of the General Partner
of Aries Domestic, which is located at 787 Seventh Avenue, 48th Floor, New York,
New York, 10019, is as follows:
                                            
                                                     PRINCIPAL OCCUPATION
         NAME                                        OR EMPLOYMENT

Paramount Capital Asset Management, Inc.    General Partner; Investment Manager

         Exhibit B is hereby incorporated by reference.

Item 2.

         During the five years prior to the date  hereof,  the above  person (to
the best of Aries  Domestic's  knowledge)  has not been  convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) or was a party
to a  civil  proceeding  of a  judicial  or  administrative  body  of  competent
jurisdiction,  as a result of which such person was or is subject to a judgment,
decree  or final  order  enjoining  future  violations  of,  or  prohibiting  or
mandating activities subject to, Federal or State securities laws or finding any
violation with respect to such laws.

Items 3-6.

         Please refer to Items 3-6 herein reporting the beneficial ownership.

                                       11

<PAGE>

                                                              EXHIBIT D

         The name and principal  occupation or employment,  which in the case of
Paramount Capital Asset Management,  Inc. is located at 787 Seventh Avenue, 48th
Floor,  New York, New York,  10019,  of each  executive  officer and director of
Aries Trust is as follows:

                                                   PRINCIPAL OCCUPATION
         NAME                                      OR EMPLOYMENT

Paramount Capital Asset Management, Inc.        Investment Manager

MeesPierson (Cayman) Limited                    Trustee
P.O. Box 2003
British American Centre
Phase 3, Dr. Roy's Drive
George Town, Grand Cayman

         Exhibit B is hereby incorporated by reference.

Item 2.

         During the five years  prior to the date  hereof,  neither of the above
persons  (to the best of Aries  Trust's  knowledge)  have  been  convicted  in a
criminal  proceeding  (excluding traffic violations or similar  misdemeanors) or
was a party  to a civil  proceeding  of a  judicial  or  administrative  body of
competent jurisdiction,  as a result of which such person was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities subject to, Federal or State securities laws or finding
any violation with respect to such laws.

Items 3-6.

         Please refer to Items 3-6 herein reporting the beneficial ownership.

                                       12



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission